FDA 510(k) FDA class 2 Substantially Equivalent 🇩🇪 Germany

INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)

K Number: K240315 · Decision Oct 10, 2024
Classifications
1
FEI Numbers
3
Registration Numbers
3
Same Product Code
2
Applicant Total
19
Review Days
251

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)
K Number
K240315
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
864.7295
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Siemens Healthcare Diagnostics Products GmbH
Date Received
February 2, 2024
Decision Date
October 10, 2024
Product Code
QLU
Advisory Committee
Hematology
Review Advisory Committee
HE
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QLU Anti-Factor Xa Activity Test System, Apixaban

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (QLU), ordered by most recent decision date.

View all

Other Clearances by Siemens Healthcare Diagnostics Products GmbH

K Number Device Name
K233663 N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)
K220728 vWF Ag
K212559 CardioPhase® hsCRP
DEN200067 INNOVANCE VWF Ac
K212379 N Latex FLC kappa, N Latex FLC lambda
K201496 N Latex FLC kappa, N Latex FLC lambda
K193047 N Latex FLC kappa, N Latex FLC lambda
K190879 N Latex FLC kappa, N Latex FLC lambda
K182098 N Latex FLC kappa assay, N Latex FLC lambda assay
K181525 INNOVANCE Free PS Ag
Search all 19 clearances from Siemens Healthcare Diagnostics Products GmbH →